🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validation of Uzbek-Language ADAM, AMS, and IPSS Questionnaires in Men Aged 35-59 Years

Recruitingn/aAges 35 Years - 59 YearsMaleAndijan State Medical Institute
NCT07879183 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study aims to evaluate the reliability and validity of the Uzbek-language versions of three questionnaires used to assess men's health: the Androgen Deficiency in Aging Males (ADAM), Aging Males' Symptoms (AMS), and International Prostate Symptom Score (IPSS). The study will include approximately 400 men aged 35-59 years from the Andijan region of Uzbekistan. Participants will complete all three questionnaires electronically using Google Forms. At least 120 participants will complete the questionnaires again after 7-14 days to assess the consistency of their responses. Blood samples will be collected to measure total testosterone levels and examine their relationship with questionnaire results. The study will also assess how well ADAM identifies men with low testosterone levels and how reliably AMS and IPSS measure their respective symptoms. No treatment or experime

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male participants aged 35-59 years. * Ability to understand and complete questionnaires in the Uzbek language. * Willingness to provide written informed consent. Exclusion Criteria: * Severe cognitive impairment preventing reliable questionnaire completion. * Acute illness or medical conditions substantially interfering with participation. * Inability to complete the questionnaires or provide reliable responses despite standardized instructions. * Previous participation in the preliminary psychometric evaluation of the Uzbek-language ADAM, AMS, and IPSS questionnaires. Chronic diseases, lower urinary tract symptoms, and previously diagnosed hypogonadism will not automatically constitute exclusion criteria. Relevant diagnoses, medications, and concomitant conditions will be recorded for analysis.
💊

What it tests

  • Not listed
📍

Where

1 site
Andijan State Medical Institute
Andijan, Uzbekistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy